Expression of activation-induced cytidine deaminase enhances the clearance of pneumococcal pneumonia: evidence of a subpopulation of protective anti-pneumococcal B1a cells

Immunology. 2016 Jan;147(1):97-113. doi: 10.1111/imm.12544.

Abstract

We describe a protective early acquired immune response to pneumococcal pneumonia that is mediated by a subset of B1a cells. Mice deficient in B1 cells (xid), or activation-induced cytidine deaminase (AID(-/-) ), or invariant natural killer T (iNKT) cells (Jα18(-/-) ), or interleukin-13 (IL-13(-/-) ) had impaired early clearance of pneumococci in the lung, compared with wild-type mice. In contrast, AID(-/-) mice adoptively transferred with AID(+/+) B1a cells, significantly cleared bacteria from the lungs as early as 3 days post infection. We show that this early bacterial clearance corresponds to an allergic contact sensitivity-like cutaneous response, probably due to a subpopulation of initiating B1a cells. In the pneumonia model, these B1a cells were found to secrete higher affinity antigen-specific IgM. In addition, as in contact sensitivity, iNKT cells were required for the anti-pneumococcal B1a cell initiating response, probably through early production of IL-13, given that IL-13(-/-) mice also failed to clear infection. Our study is the first to demonstrate the importance of AID in generating an appropriate B1a cell response to pathogenic bacteria. Given the antibody affinity and pneumonia resistance data, natural IgM produced by conventional B1a cells are not responsible for pneumonia clearance compared with the AID-dependent subset.

Keywords: B1a cells; IgM antibody; activation-induced cytidine deaminase; interleukin-13; invariant natural killer T cells; pneumococcal pneumonia.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptive Immunity*
  • Adoptive Transfer
  • Agammaglobulinaemia Tyrosine Kinase
  • Animals
  • Antigens, Bacterial / immunology
  • B-Lymphocytes / enzymology*
  • B-Lymphocytes / immunology
  • B-Lymphocytes / microbiology
  • B-Lymphocytes / transplantation
  • Complement Activation
  • Cytidine Deaminase / deficiency
  • Cytidine Deaminase / genetics
  • Cytidine Deaminase / immunology
  • Cytidine Deaminase / metabolism*
  • Cytokines / immunology
  • Cytokines / metabolism
  • Dermatitis, Contact / enzymology
  • Dermatitis, Contact / immunology
  • Dermatitis, Contact / microbiology
  • Disease Models, Animal
  • Genotype
  • Immunoglobulin M / immunology
  • Immunoglobulin M / metabolism
  • Interleukin-13 / deficiency
  • Interleukin-13 / genetics
  • Lung / enzymology*
  • Lung / immunology
  • Lung / microbiology
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Inbred CBA
  • Mice, Knockout
  • Natural Killer T-Cells / immunology
  • Natural Killer T-Cells / microbiology
  • Phagocytosis*
  • Phenotype
  • Pneumonia, Pneumococcal / enzymology*
  • Pneumonia, Pneumococcal / immunology
  • Pneumonia, Pneumococcal / microbiology
  • Protein-Tyrosine Kinases / immunology
  • Protein-Tyrosine Kinases / metabolism
  • Spleen / enzymology
  • Spleen / immunology
  • Spleen / microbiology
  • Streptococcus pneumoniae / immunology*
  • Streptococcus pneumoniae / pathogenicity
  • Time Factors

Substances

  • Antigens, Bacterial
  • Cytokines
  • Immunoglobulin M
  • Interleukin-13
  • Protein-Tyrosine Kinases
  • Agammaglobulinaemia Tyrosine Kinase
  • Btk protein, mouse
  • AICDA (activation-induced cytidine deaminase)
  • Cytidine Deaminase